Metsera says Novo Nordisk’s new bid for obesity drugmaker is ‘superior’ to revised Pfizer offer

Thread starter International: Top News And Analysis
Start date Nov 4, 2025

International: Top News And Analysis

Guest

Nov 4, 2025

The clash reflects the shifting landscape for weight loss and diabetes drugs, with Novo Nordisk trailing Eli Lilly as companies like Pfizer race to break in.

Continue reading...

You must log in or register to reply here.

Facebook X Bluesky LinkedIn Reddit Pinterest Tumblr WhatsApp Email Link

Thread Information

Title: Metsera says Novo Nordisk’s new bid for obesity drugmaker is ‘superior’ to revised Pfizer offer

Prefix: N/A

Forum: World News

Start date: Nov 4, 2025

Last reply date: Nov 4, 2025

Replies: 0

Thread Tags

Thread statistics

Created: International: Top News And Analysis, Nov 4, 2025

Replies: 0

Views: 17

About Us

XenTR Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout.

Color picker

Search